SCOPUS 정보 검색 플랫폼

Canadian Journal of Gastroenterology

Volumn 26, Issue 3, 2012, Pages 148-150

Reassessing the role for lamivudine in chronic hepatitis B infection: A four-year cohort analysis

(2) Shaikh, Tahir a Cooper, Curtis b

a UNIVERSITY OF OTTAWA (Canada)

b UNIVERSITY OF OTTAWA (Canada)

Author keywords

3TC; Antivirals; HBV; Heptovir; Lamivudine; Viremia

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEPATITIS B; HUMAN; MALE; PRIORITY JOURNAL; SEROLOGY; TREATMENT FAILURE; TREATMENT RESPONSE; VIREMIA;

EID: 84858241919 PISSN: 08357900 EISSN: None Source Type: Journal
DOI: 10.1155/2012/936259 Document Type: Article

Times cited : (9)

References (9)

1
- 34547426887
- Management of chronic hepatitis B: Consensus guidelines
- Sherman M, Shafran S, Burak K, et al. Management of chronic hepatitis B: Consensus guidelines. Can J Gastroenterol 2007;21(Suppl C):5C-24C. (Pubitemid 47162250)
- (2007) Canadian Journal of Gastroenterology , vol.21 , Issue.SUPPL. C
- Sherman, M.¹ Shafran, S.² Burak, K.³ Doucette, K.⁴ Wong, W.⁵ Girgrah, N.⁶ Yoshida, E.⁷ Renner, E.⁸ Wong, P.⁹ Deschenes, M.¹⁰

2
- 77957376794
- Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection
- Berg T, Marcellin P, Zoulim F, et al. Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Gastroenterology 2010;139:1207-17.
- (2010) Gastroenterology , vol.139 , pp. 1207-1217
- Berg, T.¹ Marcellin, P.² Zoulim, F.³

3
- 33644818518
- A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
- DOI 10.1056/NEJMoa051285
- Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006;354:1001-10. (Pubitemid 43357804)
- (2006) New England Journal of Medicine , vol.354 , Issue.10 , pp. 1001-1010
- Chang, T.-T.¹ Gish, R.G.² De Man, R.³ Gadano, A.⁴ Sollano, J.⁵ Chao, Y.-C.⁶ Lok, A.S.⁷ Han, K.-H.⁸ Goodman, Z.⁹ Zhu, J.¹⁰ Cross, A.¹¹ DeHertogh, D.¹² Wilber, R.¹³ Colonno, R.¹⁴ Apelian, D.¹⁵

4
- 0037443950
- Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
- DOI 10.1086/368083
- Lai CL, Dienstag J, Schiff E, et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 2003;36:687-96. (Pubitemid 36337972)
- (2003) Clinical Infectious Diseases , vol.36 , Issue.6 , pp. 687-696
- Lai, C.-L.¹ Dienstag, J.² Schiff, E.³ Leung, N.W.Y.⁴ Atkins, M.⁵ Hunt, C.⁶ Brown, N.⁷ Woessner, M.⁸ Boehme, R.⁹ Condreay, L.¹⁰

5
- 0032499913
- A one-year trial of lamivudine for chronic hepatitis B
- DOI 10.1056/NEJM199807093390201
- Lai CL, Chien RN, Leung NW, et al. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. N Engl J Med 1998;339:61-8. (Pubitemid 28304879)
- (1998) New England Journal of Medicine , vol.339 , Issue.2 , pp. 61-68
- Lai, C.-L.¹ Chien, R.-N.² Leung, N.W.Y.³ Chang, T.-T.⁴ Guan, R.⁵ Tai, D.-I.⁶ Ng, K.-Y.⁷ Wu, P.-C.⁸ Dent, J.C.⁹ Barber, J.¹⁰ Stephenson, S.L.¹¹ Gray, D.F.¹²

6
- 0034105307
- Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial
- DOI 10.1136/gut.46.4.562
- Schalm SW, Heathcote J, Cianciara J, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial. Gut 2000;46:562-8. (Pubitemid 30305823)
- (2000) Gut , vol.46 , Issue.4 , pp. 562-568
- Schalm, S.W.¹ Heathcote, J.² Cianciara, J.³ Farrell, G.⁴ Sherman, M.⁵ Willems, B.⁶ Dhillon, A.⁷ Moorat, A.⁸ Barber, J.⁹ Gray, D.F.¹⁰

7
- 77956904070
- Management of hepatitis B: A longitudinal national survey - Impact of the Canadian hepatitis B consensus guidelines
- Marotta P, Lucas K. Management of hepatitis B: A longitudinal national survey - impact of the Canadian hepatitis B consensus guidelines. Can J Gastroenterol 2010;24:537-542.
- (2010) Can J Gastroenterol , vol.24 , pp. 537-542
- Marotta, P.¹ Lucas, K.²

8
- 19544391413
- Lamivudine for patients with chronic hepatitis B and advanced liver disease
- Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521-31.
- (2004) N Engl J Med , vol.351 , pp. 1521-1531
- Liaw, Y.F.¹ Sung, J.J.² Chow, W.C.³

9
- 0035718977
- Chronic hepatitis B infection in Canada
- Minuk G, Uhanova J. Chronic hepatitis B infection in Canada. Can J Infect Dis 2001;12:351-6.
- (2001) Can J Infect Dis , vol.12 , pp. 351-356
- Minuk, G.¹ Uhanova, J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.